Universal Biosensors, Inc.

Total Valuation

Universal Biosensors, Inc. carries a market capitalization of 4.17M, placing it among publicly traded companies globally. Its enterprise value stands at 11.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Universal Biosensors, Inc. currently has 298.07M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 1.75, and the price-to-book ratio stands at -0.08.

Enterprise Valuation

Financial Position

Universal Biosensors, Inc. maintains a current ratio of 1.90, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.03, indicating elevated leverage, while an interest coverage ratio of -1,723.14 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Universal Biosensors, Inc.'s stock has declined approximately -80.55556% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.06.

Income Statement

Over the trailing twelve months, Universal Biosensors, Inc. generated 5.95M in revenue and converted that into -17.46M in net income, yielding earnings per share of -0.06. EBITDA reached -17.12M, while operating income came in at -17.78M.

Balance Sheet

Universal Biosensors, Inc. holds 2.20M in cash and equivalents against 3.05M in total debt, resulting in a net debt position of -1.99M. Total book value stands at -124.08M, with working capital of 3.81M providing operational flexibility.

Cash Flow

Universal Biosensors, Inc. produced -12.97M in operating cash flow over the past twelve months. After subtracting -340,158.00 in capital expenditures, free cash flow totaled -13.31M - equivalent to -0.04 per share.

Margins

Universal Biosensors, Inc. operates with a gross margin of 26.73, reflecting its pricing power and cost economics. The operating margin of -298.73 and net profit margin of -293.32 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Universal Biosensors, Inc.'s most recent stock split took place on April 15, 2024 with a 1000:1059 split ratio.

Scores

Universal Biosensors, Inc. posts an Altman Z-Score of -14.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.